Thursday, 16 October 2014

Diabetes 2012 Conference | Dr. Srikanth's Diabetes - Vijayawada

Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada chairing scientific sessions at Clinical Research to Practice - YDRF Diabetes 2012 Conference, which was held at Vijayawada on 28-29th July 2012.

Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. K. Srikanth, Consultant Endocrinologist @ Endolife Hospital - Guntur, Chairing a scientific session on “GLP-1 & HEART – WHAT IS THE EVIDENCE” by Dr. Ganapathi at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. Heart friendliness of GLP-1 analogues, not only by reducing the HbA1c, weight, waist circumference, lipids, Systolic & diastolic numbers, but also by an independent manner were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. Sri Lakshmi, Chief Anaesthetist @ Nagarjuna Hospital - Kanuruu, Chairing a scientific session on “IN HOSPITAL MANAGEMENT OF DIABETES – IN ICU’S MEDICAL AND SURGICAL WARDS” by Dr. Vageesh Ayyar at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. Hyperglycemia management protocols for ICUs / hospital wards and role of infections and emergency drugs in dysglycemia were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. K. Srikanth, Consultant Endocrinologist @ Endocrine Hospital - Guntur, Chairing a scientific session on “GLP-1 & HEART – WHAT IS THE EVIDENCE” by Dr. Ganapathi at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. Heart friendliness of GLP-1 analogues, not only by reducing the HbA1c, weight, waist circumference, lipids, Systolic & diastolic numbers, but also by an independent manner were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. Sri Lakshmi, Chief Anaesthetist @ Nagarjuna Hospital - Kanuruu, Chairing a scientific session on “IN HOSPITAL MANAGEMENT OF DIABETES – IN ICU’S MEDICAL AND SURGICAL WARDS” by Dr. Vageesh Ayyar at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. Hyperglycemia management protocols for ICUs / hospital wards and role of infections and emergency drugs in dysglycemia were highlighted during the session. 
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. T. Sateesh Chandra, Consultant Endocrinologist @ Endocare Hospital - Vijayawada, Chairing a scientific session on “INCRETINS AND CV PROTECTION” by Dr. R. Santosh at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. With incretin based therapies gaining momentum in Diabetes management, their benefits in reducing the HbA1c, weight, lipids, Systolic & diastolic numbers for better Cardio vascular outcomes were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. T. Sateesh Chandra, Consultant Endocrinologist @ Endocare Hospital - Vijayawada, Chairing a scientific session on “INCRETINS AND CV PROTECTION” by Dr. R. Santosh at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. With incretin based therapies gaining momentum in Diabetes management, their benefits in reducing the HbA1c, weight, lipids, Systolic & diastolic numbers for better Cardio vascular outcomes were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. T. Sateesh Chandra, Consultant Endocrinologist @ Endocare Hospital - Vijayawada, Chairing a scientific session on “INCRETINS AND CV PROTECTION” by Dr. R. Santosh at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. With incretin based therapies gaining momentum in Diabetes management, their benefits in reducing the HbA1c, weight, lipids, Systolic & diastolic numbers for better Cardio vascular outcomes were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. T. Sateesh Chandra, Consultant Endocrinologist @ Endocare Hospital - Vijayawada, Chairing a scientific session on “INCRETINS AND CV PROTECTION” by Dr. R. Santosh at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. With incretin based therapies gaining momentum in Diabetes management, their benefits in reducing the HbA1c, weight, lipids, Systolic & diastolic numbers for better Cardio vascular outcomes were highlighted during the session.
Dr. M. Srikanth, Chief Diabetologist @ Dr. Srikanth's Diabetes Specialities Centre - Vijayawada and Dr. Sri Lakshmi, Chief Anaesthetist @ Nagarjuna Hospital - Kanuruu, Chairing a scientific session on “IN HOSPITAL MANAGEMENT OF DIABETES – IN ICU’S MEDICAL AND SURGICAL WARDS” by Dr. Vageesh Ayyar at Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012. Hyperglycemia management protocols for ICUs / hospital wards and role of infections and emergency drugs in dysglycemia were highlighted during the session.
News coverage on Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012.
News coverage on Clinical Research to Practice YDRF Diabetes 2012 Conference, held at Vijayawada on 28-29th July 2012.

Wednesday, 19 March 2014

New stick-on diabetes device offers a break from finger pricking

Diabetics who must prick their fingers to test levels every day often end up with sore and calloused hands – which is why needle-free devices are always a welcome arrival in the treatment market.

New glucose sensor on the scene that can be worn on the back of the upper arm and monitors glucose levels for up to 14 days. The Libre sensor can work for both type 1 and type 2 diabetes and it continuously monitors blood sugar levels from a 5mm-long prong that is nestled under the skin and reacts with bodily fluids.

Finger pricking can lead to poor diabetes control if patients struggle to prick often enough due to irritation or inconvenience. “Finger-¬pricking is a hassle and can be embarrassing,". "Many people forget to do it so don’t have a complete ¬picture of their condition. Failing to control long-term ¬diabetes can cause diabetic ¬retino¬pathy, renal failure and foot comp¬lications that can lead to ¬amputation."

Without consistent readings, patients can't get an accurate picture of their daily blood sugar patterns – a problem the new sensor aims to solve. The Libre can store up to eight hours worth of data before it must be downloaded, and it can work through clothing. If approved, the device could be on the market for sale later this year.